The WHO chief says an Ebola outbreak in the Democratic Republic of the Congo is spreading at an unprecedented rate. The outbreak has killed 1,751 people.
4:52 PMAl Jazeera38 stories from 12 sources
Ebola accelerates as health systems strain across outbreaks and markets
Day’s Recap
Supporting Articles
A river boat in the Democratic Republic of Congo has been placed under quarantine after five deaths, with health officials screening all passengers for Ebola.
10:04 AMBBC
Health workers in the Democratic Republic of Congo are protesting unpaid wages as Ebola deaths exceed 1,800 and the outbreak spreads into remote areas.
9:07 AMAl Jazeera
An Ebola outbreak is worsening while healthcare workers strike over unpaid or inadequate compensation. The labor dispute is disrupting the response as the disease continues to spread.
7:20 AMAl Jazeera
Child wasting, the most dangerous form of acute malnutrition, has reached critical levels in one-third of Afghanistan’s provinces.
8:30 AMAl Jazeera
The CDC linked a salmonella outbreak that has sickened hundreds of people across 27 US states to jalapeno peppers imported from Mexico.
2:47 PMAl Jazeera
CDC and FDA are investigating a Salmonella outbreak linked to jalapenos from Mexico that has sickened 345 people across 27 states. A recall is underway.
9:13 AMCNBC
The FDA approved Replimune's treatment for advanced melanoma after rejecting the drug twice. The decision delivers a major regulatory win for the company and patient advocates after a prolonged review process.
3:59 PMStat News
An advocacy group says a little-noticed policy change delayed Medicare's selection of a costly AbbVie medicine for price negotiations by seven years. The delay kept the drug outside the immediate reach of the federal price-setting process.
3:00 PMStat News
Families are suing New York City after a Harlem Legionnaires' outbreak linked to two city-owned sites killed residents and sickened others. The lawsuits allege that improperly maintained cooling towers released dangerous bacteria.
6:55 PMNYT New York
Eli Lilly expanded its lead in the obesity-drug market after its latest earnings report, while Novo Nordisk continued working to recover market share and rebuild confidence in its pipeline. The results sharpened the contrast between the companies' commercial momentum.
12:28 PMCNBC
Wegovy transformed Novo Nordisk into Europe’s most valuable company, but a failed clinical trial and intensifying US competition have complicated its growth outlook. The company is betting on continued innovation and oral weight-loss drugs to find its next major product.
8:31 AMFortune
Health officials found West Nile virus in nearly twice as many tested mosquito pools as at the same point last year. They are expanding mosquito control and urging residents to use repellent and remove standing water.
3:35 PMGothamist4:52 PMAl Jazeera
WHO chief: Ebola outbreak in DRC spreading at ‘unprecedented rate’
Summary
The WHO chief says an Ebola outbreak in the Democratic Republic of the Congo is spreading at an unprecedented rate. The outbreak has killed 1,751 people.
The speed of transmission and scale of deaths indicate that containment efforts are falling behind
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Rapid transmission and a high death toll increase the risk that local health systems will be overwhelmed and the outbreak will spread beyond affected areas.
10:04 AMBBC
DR Congo river boat under quarantine for Ebola after five deaths
Summary
A river boat in the Democratic Republic of Congo has been placed under quarantine after five deaths, with health officials screening all passengers for Ebola.
The quarantine reflects the risk that river transport could carry Ebola from an affected area
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A mobile outbreak on a major river route could spread the virus faster than local health systems can detect it.
9:07 AMAl Jazeera
DR Congo Ebola health workers protest unpaid wages as deaths surpass 1,800
Summary
Health workers in the Democratic Republic of Congo are protesting unpaid wages as Ebola deaths exceed 1,800 and the outbreak spreads into remote areas.
Unpaid workers are weakening the response at the moment the virus is expanding beyond easier-to-reach
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A public-health response cannot contain Ebola when the workforce responsible for it is demoralized and unsupported.
7:20 AMAl Jazeera
Ebola outbreak accelerates as healthcare workers strike over pay
Summary
An Ebola outbreak is worsening while healthcare workers strike over unpaid or inadequate compensation. The labor dispute is disrupting the response as the disease continues to spread.
The strike removes capacity from the exact services needed to contain Ebola, including case detection,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A weakened health workforce can turn a containable Ebola outbreak into a broader regional emergency.
8:30 AMAl Jazeera
Deadliest form of malnutrition has reached critical levels in Afghanistan
Summary
Child wasting, the most dangerous form of acute malnutrition, has reached critical levels in one-third of Afghanistan’s provinces.
The scale of severe wasting signals a rapidly worsening nutrition crisis, especially for children who
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Severe child wasting becomes fatal quickly, so delayed aid will translate directly into preventable deaths.
2:47 PMAl Jazeera
CDC says US salmonella outbreak tied to jalapeno peppers from Mexico
Summary
The CDC linked a salmonella outbreak that has sickened hundreds of people across 27 US states to jalapeno peppers imported from Mexico.
The investigation shifts attention from individual illnesses to a potentially contaminated food supply spanning multiple
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A widely distributed ingredient can turn a localized contamination problem into a multistate public-health threat.
9:13 AMCNBC
Mexican jalapenos tied to Salmonella outbreak in 27 U.S. states
Summary
CDC and FDA are investigating a Salmonella outbreak linked to jalapenos from Mexico that has sickened 345 people across 27 states. A recall is underway.
The outbreak's multistate spread has triggered a coordinated federal investigation and product recall. Consumers, retailers,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The scale of the outbreak raises the risk of further illnesses before contaminated products are fully identified and removed.
3:59 PMStat News
STAT+: FDA approves Replimune melanoma drug previously rejected twice
Summary
The FDA approved Replimune's treatment for advanced melanoma after rejecting the drug twice. The decision delivers a major regulatory win for the company and patient advocates after a prolonged review process.
The approval reverses the drug's regulatory trajectory and gives patients with advanced melanoma another treatment
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The decision expands melanoma treatment choices and shows that a twice-rejected therapy can still reach patients after further regulatory review.
3:00 PMStat News
STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
Summary
An advocacy group says a little-noticed policy change delayed Medicare's selection of a costly AbbVie medicine for price negotiations by seven years. The delay kept the drug outside the immediate reach of the federal price-setting process.
The alleged policy shift could materially extend the period during which Medicare pays the drug's
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A seven-year delay would show how administrative decisions can substantially limit Medicare's ability to reduce spending on blockbuster medicines.
6:55 PMNYT New York
Families Sue New York City Over Deaths in 2025 Legionnaires’ Outbreak
Summary
Families are suing New York City after a Harlem Legionnaires' outbreak linked to two city-owned sites killed residents and sickened others. The lawsuits allege that improperly maintained cooling towers released dangerous bacteria.
The claims place responsibility for the deaths on failures at city-controlled facilities, rather than treating
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The suits could determine whether city agencies and contractors face substantial liability for preventable Legionnaires' infections.
3 stories · 3 sources
12:28 PMCNBC
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
Summary
Eli Lilly expanded its lead in the obesity-drug market after its latest earnings report, while Novo Nordisk continued working to recover market share and rebuild confidence in its pipeline. The results sharpened the contrast between the companies' commercial momentum.
Lilly now has more room to shape pricing, supply, and prescribing trends in the obesity
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The obesity-drug race is becoming a test of sustained product execution, not just which company reaches patients first.
8:31 AMFortune
Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult
Summary
Wegovy transformed Novo Nordisk into Europe’s most valuable company, but a failed clinical trial and intensifying US competition have complicated its growth outlook. The company is betting on continued innovation and oral weight-loss drugs to find its next major product.
Novo Nordisk now must reduce its dependence on Wegovy while defending its position in an
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The company’s valuation and future growth now depend on turning obesity-drug leadership into a broader product pipeline.
3:35 PMGothamist
West Nile virus detected in nearly twice as many NYC mosquito pools as last year
Summary
Health officials found West Nile virus in nearly twice as many tested mosquito pools as at the same point last year. They are expanding mosquito control and urging residents to use repellent and remove standing water.
The increase broadens the period and geography in which New Yorkers face mosquito-borne disease risk.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
More infected mosquito pools raise the chance of human cases and make household prevention part of the city's response.
Other Developments
A curated list of other prominent stories from this day.
Michigan is easing its lettuce-related public health advice as reports of cyclosporiasis decline. The outbreak has been linked to two deaths, both involving people with significant underlying health conditions.
5:28 PMCNBCUS hospitals are emerging from a period of financial recovery just as federal policy changes and rising demand from aging baby boomers begin to pressure the sector.
1:56 PMBloomberg Markets
Oscar Health reported record first-half profitability and a 70% increase in revenue to $4.9 billion, while Oscar and GoodRx emphasized technology as customer needs evolve.
1:40 PMPYMNTS
Fortis Healthcare’s consolidated first-quarter profit rose 2.3% to Rs 273 crore, while revenue increased 17.5% to Rs 2,545 crore. Hospital operations and diagnostics supported the growth, alongside continued infrastructure investment.
11:53 AMEconomic TimesRoivant CEO Matt Gline expects the FDA to approve the company's drug for a debilitating skin disease, with a commercial launch targeted for September.
11:37 AMBloomberg Markets
A new study identifies a previously unknown role for tau in the neurodegenerative processes associated with Alzheimer's disease. The finding adds biological support to efforts to develop drugs that target tau.
11:00 AMStat News
The FDA approved Takeda's narcolepsy drug and the first mRNA flu vaccine, alongside other biotechnology developments. The approvals add new options in sleep medicine and influenza prevention.
9:49 AMStat News
Federal authorities are moving to close a Kentucky organ donation organization accused of pursuing organ recovery from patients who unexpectedly showed signs of life.
9:47 AMStat News
The article calls for an independent, transparent investigation into the U.S. Covid-19 response, modeled on the commission created after the September 11 attacks.
9:38 AMStat News
A study of nearly 4,000 infants found no meaningful safety difference between acetaminophen and ibuprofen during infancy. Neither drug was linked to eczema or bronchiolitis, and the researchers reported no serious drug-related side effects.
8:43 AMScienceDaily
The end of Temporary Protected Status for Haitian healthcare workers is raising concern among New York nursing homes, caregivers and patient advocates. Employers and frontline workers warn that losing Haitian staff will deepen workforce shortages and affect patient care.
6:30 AMGothamist
A long-term brain study linked smoking, high blood pressure, heart disease, and elevated blood lipids to brain damage associated with vascular dementia. The findings suggest that controlling several modifiable risks could delay or reduce dementia-related injury.
6:23 AMScienceDaily
Researchers linked a faulty collagen-related gene to mineral buildup and spinal fusion in zebrafish, changes that resemble human disc disease. An existing osteoporosis drug, along with a treatment targeting fat metabolism, reduced the damage.
5:50 AMScienceDaily
Preliminary reports of talks between AstraZeneca and Bristol Myers Squibb sent shares higher and revived debate about a potential deal. Such a transaction would represent a major consolidation move among large drugmakers.
5:40 AMCNBCManipal Health Enterprises plans to use proceeds from its IPO to reduce debt and fund expansion across India. Its leadership also discussed valuation concerns, acquisitions and a continued focus on the domestic market.
2:35 AMBloomberg Markets5:28 PMCNBC
Michigan eases lettuce advice as state health department says cyclosporiasis reports decline
Summary
Michigan is easing its lettuce-related public health advice as reports of cyclosporiasis decline. The outbreak has been linked to two deaths, both involving people with significant underlying health conditions.
The decline in reports signals that the outbreak may have passed its peak, but the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Fewer cases may support relaxed consumer advice, but the deaths keep the outbreak a serious concern for vulnerable populations.
1:56 PMBloomberg Markets
Hospital Sector to See K-Shaped Path, Federal Cuts Expected
Summary
US hospitals are emerging from a period of financial recovery just as federal policy changes and rising demand from aging baby boomers begin to pressure the sector.
The recovery is likely to split the industry rather than lift it evenly. Well-capitalized systems
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Federal cuts could widen the gap between financially resilient health systems and hospitals already operating with limited margin.
1:40 PMPYMNTS
GoodRx and Oscar Health Tout Tech as Consumer Needs Change
Summary
Oscar Health reported record first-half profitability and a 70% increase in revenue to $4.9 billion, while Oscar and GoodRx emphasized technology as customer needs evolve.
Oscar's results show that scale and technology can support rapid growth as consumers demand more
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Healthcare technology is becoming a competitive tool for controlling costs and retaining consumers as insurance and medication needs change.
11:53 AMEconomic Times
Fortis Healthcare Q1 Results: Profit rises 2.3% to Rs 273 crore
Summary
Fortis Healthcare’s consolidated first-quarter profit rose 2.3% to Rs 273 crore, while revenue increased 17.5% to Rs 2,545 crore. Hospital operations and diagnostics supported the growth, alongside continued infrastructure investment.
Revenue growth substantially outpaced profit growth, indicating that margin expansion remains limited despite strong operating
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Fortis is growing quickly, but investors will need evidence that higher revenue converts into stronger margins.
11:37 AMBloomberg Markets
Roivant Expects FDA to Approve First Major Drug
Summary
Roivant CEO Matt Gline expects the FDA to approve the company's drug for a debilitating skin disease, with a commercial launch targeted for September.
FDA approval would give Roivant its first major commercial product and shift the company from
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Approval could mark Roivant's transition into a commercial pharmaceutical company and establish its first meaningful revenue stream.
11:00 AMStat News
STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development
Summary
A new study identifies a previously unknown role for tau in the neurodegenerative processes associated with Alzheimer's disease. The finding adds biological support to efforts to develop drugs that target tau.
The result broadens the case for tau-directed treatments beyond simply removing tau aggregates from the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A clearer map of tau's role could expand the targets and strategies available in Alzheimer's drug development.
9:49 AMStat News
STAT+: Two FDA approvals — a new drug and a new vaccine
Summary
The FDA approved Takeda's narcolepsy drug and the first mRNA flu vaccine, alongside other biotechnology developments. The approvals add new options in sleep medicine and influenza prevention.
The decisions extend mRNA technology into seasonal influenza and give narcolepsy patients another treatment option.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The approvals broaden the commercial and clinical reach of two technology platforms with implications beyond their initial products.
9:47 AMStat News
U.S. moves to shut a Kentucky organ donation group, citing safety failures
Summary
Federal authorities are moving to close a Kentucky organ donation organization accused of pursuing organ recovery from patients who unexpectedly showed signs of life.
The decisive issue is a breakdown in safeguards meant to confirm death before organ retrieval.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Organ donation depends on public confidence that death determinations are independent, accurate, and irreversible.
9:38 AMStat News
Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response
Summary
The article calls for an independent, transparent investigation into the U.S. Covid-19 response, modeled on the commission created after the September 11 attacks.
The proposal would move the reckoning over Covid from partisan debate to a formal review
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Without a credible review, the U.S. risks repeating the institutional failures that shaped its pandemic response.
8:43 AMScienceDaily
Major study challenges long-held fears about acetaminophen and ibuprofen use in babies
Summary
A study of nearly 4,000 infants found no meaningful safety difference between acetaminophen and ibuprofen during infancy. Neither drug was linked to eczema or bronchiolitis, and the researchers reported no serious drug-related side effects.
The results weaken concerns that either common fever and pain medicine causes these respiratory or
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Parents and clinicians gain stronger evidence for using either medicine when an infant needs symptom relief, within appropriate dosing limits.
6:30 AMGothamist
Loss of Haitian caregivers leaves void NY nursing homes, patients will 'struggle to fill'
Summary
The end of Temporary Protected Status for Haitian healthcare workers is raising concern among New York nursing homes, caregivers and patient advocates. Employers and frontline workers warn that losing Haitian staff will deepen workforce shortages and affect patient care.
Ending the humanitarian protection program removes workers from a sector already struggling to recruit and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Immigration policy is directly changing the capacity and reliability of New York's long-term-care system.
6:23 AMScienceDaily
Nearly half of dementia cases may be linked to risks you can change
Summary
A long-term brain study linked smoking, high blood pressure, heart disease, and elevated blood lipids to brain damage associated with vascular dementia. The findings suggest that controlling several modifiable risks could delay or reduce dementia-related injury.
The decisive shift is from treating dementia risk as largely fixed to targeting a cluster
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Dementia prevention may be more actionable because many of its major risk factors are already measurable and treatable.
5:50 AMScienceDaily
A drug already used for osteoporosis blocked spinal damage in a new study
Summary
Researchers linked a faulty collagen-related gene to mineral buildup and spinal fusion in zebrafish, changes that resemble human disc disease. An existing osteoporosis drug, along with a treatment targeting fat metabolism, reduced the damage.
The study shifts spinal degeneration research toward mechanisms that may be treatable before irreversible fusion
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A treatment already used in osteoporosis could offer a faster route to new therapies for degenerative back disease.
5:40 AMCNBC
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Summary
Preliminary reports of talks between AstraZeneca and Bristol Myers Squibb sent shares higher and revived debate about a potential deal. Such a transaction would represent a major consolidation move among large drugmakers.
AstraZeneca appears to be weighing U.S. scale over the recent preference for smaller, targeted acquisitions.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A transaction could reshape Big Pharma competition and signal that large-scale consolidation is returning.
2:35 AMBloomberg Markets
Manipal Health Eyes India Expansion After IPO Debut
Summary
Manipal Health Enterprises plans to use proceeds from its IPO to reduce debt and fund expansion across India. Its leadership also discussed valuation concerns, acquisitions and a continued focus on the domestic market.
The IPO gives Manipal Health capital to pursue growth while strengthening its balance sheet. That
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Manipal's post-IPO capital allocation will shape both its competitive position and the pace of consolidation in Indian healthcare.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!